No summary available
1
hour
hour
Expires:
04/22/2029
Searching for Solutions
No summary available
1
hour
hour
Expires:
04/21/2029
No summary available
1
hour
hour
Expires:
04/19/2029
No summary available
1
hour
hour
Expires:
04/20/2029
What to know about opioids.
Earn up to 5.5 ACPE contact hours during this on-demand, seven-part educational series! Webinars are immediately accessible. Register and start today!
April 2025 Kaleidoscope Newsletter AAPP Foundation President's Message: Spring 2024 AAPP 2025 Activities Sponsored by the AAPP Foundation Trauma Informed Care Session Session at AAPP 2025 Supported by Kim Tallian Bequest
Kaleidoscope Newsletter April 2025 Kaleidoscope Newsletter AAPP Foundation President's Message: Spring 2024 AAPP 2025 Activities Sponsored by the AAPP Foundation Trauma Informed Care Session Session at AAPP 2025
No summary available
No summary available
No summary available
1
hour
hour
Expires:
04/22/2029
No summary available
1
hour
hour
Expires:
04/20/2029
Psychiatric and neurologic illnesses are highly prevalent and are often suboptimally treated. Pharmacists who focus on psychiatric and neurologic diseases improve outcomes for patients with these conditions. This is important in the current health care environment as most patients with psychiatric or neurologic conditions continue to have unmet needs. Read this MHC article to learn more about the value of psychiatric and neurologic pharmacists as part of the health care team.
Access valuable psychiatric treatment guideline and clinical pearl resources at AAPP
No summary available
No summary available
No summary available
No summary available
Several hours have been reserved for discussions on current issues in practice on Sunday, 4/19 through Tuesday, 4/21. These sessions are hosted by AAPP Communities and allow for peer-to-peer collaboration and information sharing between attendees who share a special interest or practice setting and involve exchange and dialogue on issues of common interest.
Person-level characteristics were particularly strong in predicting motivation for and perceived access to daily nondrug rewards.
This study conducted a ‘mega-analysis’ integrating 11 independent resting-state functional magnetic resonance imaging datasets across five psychedelic drugs from research groups spanning three continents and five countries.
There is some evidence that dialectical behavioral/acceptance and commitment therapies, contingency management alone or with cognitive-behavioral therapy with motivation enhancement, N-acetylcysteine, cannabidiol or varenicline may facilitate abstinence, reduce use and/or support treatment completion for cannabis use disorder.
BPS is requesting applicants to serve as examination item writers for the specialty certification in Psychiatric Pharmacy (BCPP) examination. If selected, your participation will consist of access to virtual training materials, as well as access to a web-based item authoring platform to draft and submit 5-10 exam items according to assigned areas of the examination content outline beginning in late May 2026. Applications are due May 2, 2026.
These findings highlight an increased prevalence of internet addiction among adolescents, which is linked to increased levels of depression, anxiety and a lower quality of life.